IFF is engaged in the creation of flavors and fragrances used in a wide variety of consumer products and packaged goods.
GLG and IFF have joined forces to leverage each companyâ€™s strengths in order to pursue exploration and commercialization of Rebaudioside C, one of the eleven primary glycosides in the stevia leaf. Research demonstrating the glycosideâ€™s ability as a sweetness modulator in food systems provides a significant market opportunity for the companies.
According to GLG, found in the by-product of Rebaudioside A production, Rebaudioside C is produced through advanced glycoside isolation and specialized extraction processing. While in itself not a sweetener, Rebaudioside C has been trialed with nutritive sweeteners and shown to enable a 20 to 25 percent reduction in calories.
GLG has four patent applications for the separation methodologies of Rebaudioside C which have been accepted by the State Intellectual Property Bureau of the Peopleâ€™s Republic of China.
The two companies have signed an agreement for the development of high-purity Rebaudioside C extract to meet IFF product specifications. If the development is successful, the parties have negotiated preliminary heads of terms for a supply agreement including exclusive supply to IFF for high-purity Rebaudioside C as a flavor modulator.
Kevin Li, vice president of technology at GLG, said: â€œWe are pleased to be working with IFF on this new opportunity. Our industry leading capabilities in the separation of steviol glycosides, production quality, and scale coupled with IFFâ€™s global capabilities in innovation, advanced flavor systems and application possibilities for high purity Rebaudioside C make this an exciting global opportunity.
â€œAdditionally, GLG will be able to extract Rebaudioside C from our existing by-product making it the third high value added product extracted from our stevia leaf.â€
Mark Dewis, vice president of flavors R&D at IFF, said: â€œWe look forward to a fruitful relationship with GLG. As leaders in their field, we view their partnership as a critical addition to our arsenal of health and wellness solutions for our customers.â€
Will the collaboration benefit the firms?
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.